Merck Access Program Co-pay Assistance - Keytruda
Merck & Co. · Keytruda
Patient pays: $25 per administration (first $25); remainder up to $25,000 annual cap covered
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Keytruda assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Keytruda help that still works on Medicare or Medicaid - the programs copay cards leave out.
Keytruda (pembrolizumab) is a pd-1 inhibitor (immune checkpoint inhibitor) made by Merck & Co.. It is commonly prescribed for: Melanoma, Non-small cell lung cancer (NSCLC), Head and neck squamous cell carcinoma, Hodgkin lymphoma, Urothelial carcinoma, Renal cell carcinoma, Microsatellite instability-high cancers (tumor-agnostic), Triple-negative breast cancer, Endometrial carcinoma, Hepatocellular carcinoma, Esophageal/gastric cancers, Cervical cancer, Plus other oncology indications (40+).
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Merck & Co. · Keytruda
Patient pays: $25 per administration (first $25); remainder up to $25,000 annual cap covered
commercial insurance
Merck Patient Assistance Program, Inc. · Keytruda
uninsured
Common questions
Related drugs